Skip to main content

Advertisement

Log in

MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours

  • Hepatobiliary-Pancreas
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To correlate MR findings with pathology in steatotic FNHs and to compare the MR findings with those of other fatty tumours developed on noncirrhotic liver in a consecutive series of resected lesions.

Methods

Our population included resected FNH with intralesional steatosis (n = 25) and other resected fatty tumours selected as controls (hepatocellular adenomas and angiomyolipomas, n = 34). Lesions were classified into three groups: those with typical FNH without (group 1) or with (group 2) fat on MR and those with atypical lesions (group 3). In group 3, diagnostic criteria for other fatty tumours were applied.

Results

There were 9 lesions in group 1 (15.3 %), 4 in group 2 (16.8 %) and 46 in group 3 (77.9 %). Group 3 contained 12 FNHs (26 %) and all the other fatty tumours. In group 3, the association of lesion homogeneity, signal intensity similar to or slightly different from adjacent liver on in-phase T1- and T2-weighted sequences, and strong arterial enhancement was observed in 7/12 (58 %) of steatotic FNHs and 3/34 (9 %) of other tumours.

Conclusion

On MR, fat within a typical FNH should not reduce the diagnostic confidence. We recommend further investigations including liver biopsy if necessary when fatty tumours exhibit atypical MR findings.

Key Points

MRI is increasingly used to assess hepatic lesions containing fat.

Nodules of focal nodular hyperplasia often contain foci of fat.

However, steatotic FNH does not always demonstrate typical fatty features on MRI.

The main mimickers of steatotic FNHs are telangiectatic/inflammatory hepatocellular adenomas.

We recommend liver biopsy when fatty tumours exhibit atypical MR findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

FNH:

Focal nodular hyperplasia

HCA:

Hepatocellular adenoma

LFABP:

Liver fatty acid-binding protein

SAA:

Serum amyloid A

GS:

Glutamine synthetase

MRI:

Magnetic resonance imaging

H&E:

Haematoxylin-eosin

References

  1. Paradis V, Benzekri A, Dargère D et al (2004) Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 126:1323–1329

    Article  PubMed  Google Scholar 

  2. Gaffey MJ, Iezzoni JC, Weiss LM (1996) Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol 148:1089–1096

    PubMed  CAS  Google Scholar 

  3. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J (2008) Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 48:163–170

    Article  PubMed  CAS  Google Scholar 

  4. Dokmak S, Paradis V, Vilgrain V et al (2009) A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705

    Article  PubMed  Google Scholar 

  5. Farges O, Ferreira N, Dokmak S et al (2011) Changing trends in malignant transformation of hepatocellular adenoma. Gut 60:85–89

    Article  PubMed  Google Scholar 

  6. Weimann A, Ringe B, Klempnauer J et al (1997) Benign liver tumours: differential diagnosis and indications for surgery. World J Surg 21:983–990

    Article  PubMed  CAS  Google Scholar 

  7. Vilgrain V (2006) Focal nodular hyperplasia. Eur J Radiol 58:236–245

    Article  PubMed  Google Scholar 

  8. Bioulac-Sage P, Balabaud C, Bedossa P et al (2007) Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 46:521–527

    Article  PubMed  CAS  Google Scholar 

  9. Prasad SR, Wang H, Rosas H et al (2005) Fat-containing lesions of the liver: radiologic–pathologic correlation. RadioGraphics 25:321–331

    Article  PubMed  Google Scholar 

  10. Basaran C, Karcaaltincaba M, Akata D et al (2005) Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI. AJR Am J Roentgenol 184:1103–1110

    Article  PubMed  Google Scholar 

  11. Valls C, Iannacconne R, Alba E et al (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292–2308

    Article  PubMed  Google Scholar 

  12. Bioulac-Sage P, Rebouissou S, Thomas C et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748

    Article  PubMed  CAS  Google Scholar 

  13. Zucman-Rossi J, Jeannot E, Nhieu JT et al (2006) Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524

    Article  PubMed  CAS  Google Scholar 

  14. van Aalten SM, Thomeer MG, Terkivatan T et al (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181

    Article  PubMed  Google Scholar 

  15. Ronot M, Bahrami S, Calderaro J et al (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191

    Article  PubMed  Google Scholar 

  16. Laumonier H, Bioulac-Sage P, Laurent C et al (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818

    Article  PubMed  Google Scholar 

  17. Högemann D, Flemming P, Kreipe H, Galanski M (2001) Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma. Eur Radiol 11:1389–1395

    Article  PubMed  Google Scholar 

  18. Horton KM, Bluemke DA, Hruban RH, Soyer P, Fishman EK (1999) CT and MR imaging of benign hepatic and biliary tumours. RadioGraphics 19:431–451

    PubMed  CAS  Google Scholar 

  19. Bioulac-Sage P, Laumonier H, Rullier A et al (2009) Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 29:459–465

    Article  PubMed  Google Scholar 

  20. Bioulac-Sage P, Cubel G, Balabaud C et al (2011) Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis 31:91–103

    Article  PubMed  CAS  Google Scholar 

  21. Makhlouf HR, Abdul-Al HM, Goodman ZD (2005) Diagnosis of focal nodular hyperplasia of the liver by needle biopsy. Hum Pathol 36:1210–1216

    Article  PubMed  Google Scholar 

  22. Ferlicot S, Kobeiter H, Tran Van Nhieu J et al (2004) MRI of atypical focal nodular hyperplasia of the liver: radiology–pathology correlation. AJR Am J Roentgenol 182:1227–1231

    Article  PubMed  Google Scholar 

  23. Chaoui A, Mergo PJ, Lauwers GY (1998) Unusual appearance of focal nodular hyperplasia with fatty change. AJR Am J Roentgenol 171:1433–1434

    Article  PubMed  CAS  Google Scholar 

  24. Mathieu D, Paret M, Mahfouz AE et al (1997) Hyperintense benign liver lesions on spin-echo TI weighted MR images: pathologic correlations. Abdom Imaging 410–417

  25. Mitchell DG, Palazzo J, Hann HW, Rifkin MD et al (1991) Hepatocellular tumours with high signal on T1-weighted MR images: chemical shift MR imaging and histologic correlation. J Comput Assist Tomogr 15:762–769

    Article  PubMed  CAS  Google Scholar 

  26. Eisenberg LB, Warshauer DM, Woosley JT et al (1995) CT and MRI of hepatic focal nodular hyperplasia with peripheral steatosis. J Comput Assist Tomogr 19:498–500

    Article  PubMed  CAS  Google Scholar 

  27. Hussain SM, Terkivatan T, Zondervan PE et al (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. RadioGraphics 24:3–17

    Article  PubMed  Google Scholar 

  28. Grazioli L, Morana G, Kirchin MA et al (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177

    Article  PubMed  Google Scholar 

  29. Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529

    Article  PubMed  Google Scholar 

  30. Stanley G, Jeffrey RB Jr, Feliz B (2002) CT findings and mistopathology of intratumoural steatosis in focal nodular hyperplasia: case report and review of the literature. J Comput Assist Tomogr 26:815–817

    Article  PubMed  Google Scholar 

  31. Paradis V, Champault A, Ronot M et al (2007) Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 46140–46146

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maxime Ronot.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ronot, M., Paradis, V., Duran, R. et al. MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol 23, 914–923 (2013). https://doi.org/10.1007/s00330-012-2676-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-012-2676-y

Keywords

Navigation